Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance.

López-Cerero L, Bellido Mdel M, Serrano L, Liró J, Cisneros JM, Rodríguez-Baño J, Pascual A.

Enferm Infecc Microbiol Clin. 2013 Jun-Jul;31(6):385-8. doi: 10.1016/j.eimc.2012.09.005. Epub 2012 Nov 20.

PMID:
23182241
2.

Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.

Colomer-Lluch M, Mora A, López C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M, Alonso MP, Jofre J, Muniesa M, Blanco J.

J Antimicrob Chemother. 2013 Apr;68(4):758-65. doi: 10.1093/jac/dks477. Epub 2012 Dec 7.

PMID:
23221627
3.

Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.

Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.

J Antimicrob Chemother. 2009 Jun;63(6):1135-41. doi: 10.1093/jac/dkp122. Epub 2009 Apr 7.

PMID:
19351692
4.

National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Blanco JE, Alonso MP, García-Garrote F, Chaves F, Orellana MÁ, Martínez-Martínez L, Calvo J, Prats G, Larrosa MN, González-López JJ, López-Cerero L, Rodríguez-Baño J, Pascual A.

J Antimicrob Chemother. 2011 Sep;66(9):2011-21. doi: 10.1093/jac/dkr235. Epub 2011 Jun 13.

PMID:
21669946
5.

Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups.

Matsumura Y, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group.

Antimicrob Agents Chemother. 2013 Oct;57(10):4736-42. doi: 10.1128/AAC.00641-13. Epub 2013 Jul 15.

6.

Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates.

Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, Blanco M, Dahbi G, García-Garrote F, Pita JM, Coira A, Bernárdez MI, Blanco J.

Appl Environ Microbiol. 2010 Nov;76(21):6991-7. doi: 10.1128/AEM.01112-10. Epub 2010 Sep 3.

7.

Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.

Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S; Kyoto-Shiga Clinical Microbiology Study Group.

J Antimicrob Chemother. 2012 Nov;67(11):2612-20. doi: 10.1093/jac/dks278. Epub 2012 Jul 26.

8.

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.

Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.

J Antimicrob Chemother. 2009 Oct;64(4):712-7. doi: 10.1093/jac/dkp288. Epub 2009 Aug 11.

PMID:
19671590
9.

Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.

Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM.

J Antimicrob Chemother. 2015 Aug;70(8):2223-7. doi: 10.1093/jac/dkv114. Epub 2015 May 9.

10.

Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.

Peirano G, Costello M, Pitout JD.

Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.

PMID:
20359869
11.

Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.

Matsumura Y, Yamamoto M, Higuchi T, Komori T, Tsuboi F, Hayashi A, Sugimoto Y, Hotta G, Matsushima A, Nagao M, Takakura S, Ichiyama S.

Int J Antimicrob Agents. 2012 Aug;40(2):158-62. doi: 10.1016/j.ijantimicag.2012.04.013. Epub 2012 Jun 27.

12.

Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.

Mora A, Blanco M, López C, Mamani R, Blanco JE, Alonso MP, García-Garrote F, Dahbi G, Herrera A, Fernández A, Fernández B, Agulla A, Bou G, Blanco J.

Int J Antimicrob Agents. 2011 Jan;37(1):16-21. doi: 10.1016/j.ijantimicag.2010.09.012. Epub 2010 Nov 13.

PMID:
21075606
13.

CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.

Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I.

J Antimicrob Chemother. 2011 Dec;66(12):2784-90. doi: 10.1093/jac/dkr363. Epub 2011 Sep 27.

PMID:
21954457
14.

Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.

Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E.

J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20.

15.

Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.

Dahbi G, Mora A, López C, Alonso MP, Mamani R, Marzoa J, Coira A, García-Garrote F, Pita JM, Velasco D, Herrera A, Viso S, Blanco JE, Blanco M, Blanco J.

Int J Antimicrob Agents. 2013 Oct;42(4):347-51. doi: 10.1016/j.ijantimicag.2013.06.017. Epub 2013 Aug 29.

PMID:
23992646
16.

Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.

Ewers C, Grobbel M, Stamm I, Kopp PA, Diehl I, Semmler T, Fruth A, Beutlich J, Guerra B, Wieler LH, Guenther S.

J Antimicrob Chemother. 2010 Apr;65(4):651-60. doi: 10.1093/jac/dkq004. Epub 2010 Jan 29.

PMID:
20118165
17.

Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.

Matsumura Y, Nagao M, Iguchi M, Yagi T, Komori T, Fujita N, Yamamoto M, Matsushima A, Takakura S, Ichiyama S.

Clin Microbiol Infect. 2013 Feb;19(2):161-8. doi: 10.1111/j.1469-0691.2012.03762.x. Epub 2012 Feb 14.

18.

Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.

Yokota S, Sato T, Okubo T, Ohkoshi Y, Okabayashi T, Kuwahara O, Tamura Y, Fujii N.

Chemotherapy. 2012;58(1):52-9. doi: 10.1159/000336129. Epub 2012 Feb 15.

PMID:
22343392
19.
20.

Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J; Spanish Group for Nosocomial Infections (GEIH).

J Clin Microbiol. 2013 Oct;51(10):3358-67. doi: 10.1128/JCM.01555-13. Epub 2013 Aug 7.

Supplemental Content

Support Center